PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Materialtyp: Artikel
Språk:Russian
Publicerad: Remedium Group LLC 2017-11-01
Serie:Медицинский совет
Ämnen:
Länkar:https://www.med-sovet.pro/jour/article/view/2007
_version_ 1827962101507817472
author N. A. Morina
O. D. Savkova
E. A. Fedorova
I. L. Tsarev
A. B. Frolkova
A. E. Tsygankova
A. A. Sokolova
D. A. Napalkov
V. V. Fomin
author_facet N. A. Morina
O. D. Savkova
E. A. Fedorova
I. L. Tsarev
A. B. Frolkova
A. E. Tsygankova
A. A. Sokolova
D. A. Napalkov
V. V. Fomin
author_sort N. A. Morina
collection DOAJ
description Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Society of Hypertension, ESH, and the European Society of Cardiology, ESC. Thus, patients with 2–3 degree increase blood pressure (BP) and high or very high added risk often do not get the combination therapy that is required for them in this clinical environment. According to the recommendations of the ESH and ESC patients with hypertension of low/medium risk of development of cardiovascular complications (CVC) and death from them a monotherapy can be prescribed if targeted AP values are achieved [1]. Patients with high or very high risk of CCO and/or AG of Degree 2 and 3 immediately must be prescribed a combination of the two drugs. If the target blood pressure values are not attained, either a combination of two drugs at the maximum therapeutic doses, or replacement of the combination of drugs is prescribed or the 3d, 4th and so on antihypertensive drug is added [2, 3]. Combination therapy may also be administered to patients with hypertension with low/medium risk of development of CVC if the target AP are not reached [3, 4].
first_indexed 2024-04-09T16:37:09Z
format Article
id doaj.art-db9a7839943e419fa9f85836e12e9d6b
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:37:09Z
publishDate 2017-11-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-db9a7839943e419fa9f85836e12e9d6b2023-04-23T06:56:52ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-11-01012333510.21518/2079-701X-2017-12-33-351984PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITALN. A. Morina0O. D. Savkova1E. A. Fedorova2I. L. Tsarev3A. B. Frolkova4A. E. Tsygankova5A. A. Sokolova6D. A. Napalkov7V. V. Fomin8Sechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversityTreatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Society of Hypertension, ESH, and the European Society of Cardiology, ESC. Thus, patients with 2–3 degree increase blood pressure (BP) and high or very high added risk often do not get the combination therapy that is required for them in this clinical environment. According to the recommendations of the ESH and ESC patients with hypertension of low/medium risk of development of cardiovascular complications (CVC) and death from them a monotherapy can be prescribed if targeted AP values are achieved [1]. Patients with high or very high risk of CCO and/or AG of Degree 2 and 3 immediately must be prescribed a combination of the two drugs. If the target blood pressure values are not attained, either a combination of two drugs at the maximum therapeutic doses, or replacement of the combination of drugs is prescribed or the 3d, 4th and so on antihypertensive drug is added [2, 3]. Combination therapy may also be administered to patients with hypertension with low/medium risk of development of CVC if the target AP are not reached [3, 4].https://www.med-sovet.pro/jour/article/view/2007arterial hypertensioncardiovascular complicationsantihypertensive therapyangiotensin converting enzyme inhibitorsrenin-angiotensin-aldosterone system blockersslow calcium channel blockers
spellingShingle N. A. Morina
O. D. Savkova
E. A. Fedorova
I. L. Tsarev
A. B. Frolkova
A. E. Tsygankova
A. A. Sokolova
D. A. Napalkov
V. V. Fomin
PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
Медицинский совет
arterial hypertension
cardiovascular complications
antihypertensive therapy
angiotensin converting enzyme inhibitors
renin-angiotensin-aldosterone system blockers
slow calcium channel blockers
title PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
title_full PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
title_fullStr PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
title_full_unstemmed PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
title_short PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
title_sort peculiarities of antihypertensive therapy indicated in therapeutic and surgical departments of the university clinical hospital
topic arterial hypertension
cardiovascular complications
antihypertensive therapy
angiotensin converting enzyme inhibitors
renin-angiotensin-aldosterone system blockers
slow calcium channel blockers
url https://www.med-sovet.pro/jour/article/view/2007
work_keys_str_mv AT namorina peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT odsavkova peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT eafedorova peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT iltsarev peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT abfrolkova peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT aetsygankova peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT aasokolova peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT danapalkov peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital
AT vvfomin peculiaritiesofantihypertensivetherapyindicatedintherapeuticandsurgicaldepartmentsoftheuniversityclinicalhospital